Why is mitochondrial membrane potential measurement critical for target validation?

Mitochondrial membrane potential (MMP) serves as a functional readout of respiratory chain activity and cellular health, with reductions indicating early mitochondrial stress in disease models. Quantifying MMP via TMRE staining in live iPSC-derived neurons and astrocytes enables detection of compound-induced rescue or exacerbation of dysfunction. This parameter supports target validation by linking therapeutic mechanisms to bioenergetic outcomes in neurodegenerative contexts.

How does isolation of mitochondrial volume as an independent variable improve assay interpretation?

Isolating mitochondrial volume using MitoTracker Green allows normalization of other signals (e.g., MMP, ROS) to organelle content, distinguishing true functional changes from alterations in mitochondrial mass. This approach prevents misinterpretation of increased total signal as enhanced function when it may simply reflect biogenesis. Normalization to volume enables accurate assessment of specific mitochondrial activity per organelle in iPSC-derived neural and glial cells.

What quantitative dependent variable measurements enable mechanistic de-risking in screening?

Dependent variables include median fluorescence intensity of TMRE (MMP), MitoSox Red (ROS), and antibody-labeled respiratory chain subunits (e.g., Complex I, TFAM), providing quantitative, single-cell resolution readouts. These measurements allow screening campaigns to detect shifts in mitochondrial function, oxidative stress, or protein expression linked to compound treatment. By delivering continuous, quantitative data, they support dose-response modeling and hit confirmation in early discovery.

Why are replication requirements essential for cross-functional collaboration in mitochondrial profiling?

Replication ensures that observed changes in mitochondrial parameters (e.g., MMP reduction in POLG neurons) are consistent across differentiations, staining runs, and instrument settings, building confidence in assay robustness. Standardized protocols with defined cell seeding densities, staining conditions, and flow cytometer settings enable transfer between discovery biology, screening, and preclinical teams. This reproducibility supports reliable data sharing and decision-making across functional groups in drug development programs.

What statistical analysis capabilities are required before implementing this flow cytometry method?

Implementation requires capacity for median fluorescence intensity (MFI) extraction, background subtraction, and normalization to mitochondrial volume or cell count for comparative analysis. Statistical tools must support comparison of multiple conditions (e.g., control vs. disease model vs. treated) using appropriate tests for non-parametric flow cytometry data. The ability to calculate ratios such as TFAM/TOMM20 for mtDNA copy number estimation is essential for interpreting mitochondrial genome content relative to organelle abundance.

인간 유도 만능 줄기 세포와 그 신경 및 신경교 유도체에서 여러 미토콘드리아 파라미터의 유세포 분석

5.2K 조회수

인용 8회

06:09 분

2021년 11월 8일

10.3791/63116-v

2021년 11월 8일

5.2K 조회수

Kristina Xiao Liang^*¹^,² , Anbin Chen^*¹^,²^,³^,⁴ , Cecilie Katrin Kristiansen¹^,² , Laurence A. Bindoff¹^,²

¹Department of Clinical Medicine (K1), University of Bergen, ²Neuro-SysMed, Center of Excellence for Clinical Research in Neurological Diseases, Haukeland University Hospital, ³Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, ⁴Shandong Key Laboratory of Brain Function Remodeling

^* These authors contributed equally

이 연구는 미토콘드리아 부피, 미토콘드리아 막 전위, 활성 산소 종 수준, 미토콘드리아 호흡 사슬 조성 및 미토콘드리아 DNA의 변화를 감지하기 위해 두 개의 형광 리포터 또는 항체를 사용한 유세포 분석 및 이중 염색을 기반으로 여러 미토콘드리아 기능 매개 변수를 측정하는 새로운 접근 방식을보고합니다.